首页 | 本学科首页   官方微博 | 高级检索  
     


Synthesis,Biological Evaluation,and Docking Studies of New 2‐Furylbenzimidazoles as Anti‐Angiogenic Agents: Part II
Authors:Ahmed Temirak  Yasser M. Shaker  Fatma A. F. Ragab  Mamdouh M. Ali  Salwa M. Soliman  Jeremie Mortier  Gerhard Wolber  Hamed I. Ali  Hoda I. El Diwani
Affiliation:1. Division of Pharmaceutical and Drug Industries, Department of Chemistry of Natural and Microbial Products, National Research Center, Dokki, Cairo, Egypt;2. Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Cairo University, Giza, Egypt;3. Division of Genetic Engineering and Biotechnology, Department of Biochemistry, National Research Center, Cairo, Egypt;4. Department of Pharmaceutical Chemistry, Institute of Pharmacy, Free University of Berlin, Berlin, Germany;5. Department of Organic Chemistry, Free University of Berlin, Berlin, Germany;6. Department of Pharmaceutical Sciences, Irma Lerma Rangel College of Pharmacy, Texas A&M Health Science Center, Round Rock, TX, USA;7. Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Helwan University, Cairo, Egypt
Abstract:
Keywords:Angiogenesis  Cytotoxicity  2‐(2‐Furyl)‐1H‐benzimidazoles  Molecular modeling  Vascular endothelial growth factor (VEGF)
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号